欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2825/001
药品名称Eribulina EVER Pharma
活性成分
    • Eribulin 0.44 mg/ml
剂型Solution for injection
上市许可持有人Ever-Valinject GmbH
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Netherlands (NL)
      Eribulin EVER Pharma 0,44 mg/ml oplossing voor injectie
    • Czech Republic (CZ)
      Eribulin EVER Pharma
    • Romania (RO)
    • France (FR)
    • Austria (AT)
    • Bulgaria (BG)
    • Ireland (IE)
    • Hungary (HU)
      Eribulin EVER Pharma 0,44 mg/ml oldatos injekció
    • Lithuania (LT)
      Eribulin EVER Pharma 0,44 mg/ml injekcinis tirpalas
    • Belgium (BE)
      Eribulin EVER Pharma 0,44 mg/ml oplossing voor injectie
    • Poland (PL)
    • Denmark (DK)
    • Finland (FI)
    • Germany (DE)
      Eribulin EVER Pharma 0,44 mg/ml Injektionslösung
    • Norway (NO)
    • Sweden (SE)
    • Croatia (HR)
    • Greece (EL)
    • Slovak Republic (SK)
    • Spain (ES)
    • Italy (IT)
    • Slovenia (SI)
许可日期2024/03/12
最近更新日期2024/06/11
药物ATC编码
    • L01XX41 eribulin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2026 Drugfuture->European Union HMA Authorisation of Medicines DataBase